Rabies Treatment Market 2017

About Rabies Treatment
Rabies is a condition that causes thousands of deaths worldwide every year. Humans contract rabies when bitten by an animal infected with the rabies virus. The virus is transmitted when the saliva of the infected animal touches an open wound or mucous membrane. It infects the brain and ultimately leads to death.

The analysts forecast the global rabies treatment market to grow at a CAGR of 4.91% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global rabies treatment market for 2017-2021. To calculate the market size, the report considers the rabies vaccine sales for both human and animal usage.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1254684-global-rabies-treatment-market-2017-2021

 

The report, Global Rabies Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Cadila Healthcare
• GlaxoSmithKline
• Merial
• Sanofi

Other prominent vendors
• Merck
• Pfizer

Market driver
• The need for contamination-free vaccines with novel culture media

  • For a full, detailed list, view our report

Market challenge
• High maintenance costs of vaccines
• For a full, detailed list, view our report

Market trend
• Introduction of monoclonal antibodies
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

 

Complete Report Details @ https://www.wiseguyreports.com/reports/1254684-global-rabies-treatment-market-2017-2021

 

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology 

PART 04: Introduction
• Market outline

PART 05: Understanding rabies
• Disease overview
• Progression of disease
• Zoonotic diseases in developing countries
• Future prediction and prevention of rabies
• Rabies management: Current scenario

PART 06: Pipeline analysis 

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by application
• Pre-exposure vaccination
• Post-exposure prophylaxis

PART 09: Market segmentation by product type
• CCVs
• RIGs
• NTVs

PART 10: Market segmentation by route of administration
• Intradermal route of administration
• Intramuscular route of administration
• Oral route of administration

PART 11: Geographical segmentation
• Rabies treatment market in Americas
• Rabies treatment market in EMEA
• Rabies treatment market in APAC

PART 12: Decision framework 

PART 13: Drivers and challenges
• Market drivers
• Market challenges

PART 14: Market trends
• Zero human rabies by 2030 initiative
• Introduction of monoclonal antibodies
• Growing vendor interest in vaccines with short immunization periods

..…..Continued

 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1254684

 

CONTACT US:

Norah Trent

Partner Relations & Marketing Manager

sales@wiseguyreports.com

http://www.WiseGuyReports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)